BACKGROUND AND AIMS: Artificial intelligence (AI)-assisted detection is increasingly used in upper endoscopy. We performed a meta-analysis to determine the diagnostic accuracy of AI on detection of gastric and esophageal neoplastic lesions and Helicobacter pylori (HP) status. METHODS: We searched Embase, PubMed, Medline, Web of Science, and Cochrane databases for studies on AI detection of gastric or esophageal neoplastic lesions and HP status. After assessing study quality using the Quality Assessment of Diagnostic Accuracy Studies tool, a bivariate meta-analysis following a random-effects model was used to summarize the data and plot hierarchical summary receiver-operating characteristic curves. The diagnostic accuracy was determined by the area under the hierarchical summary receiver-operating characteristic curve (AUC). RESULTS: Twenty-three studies including 969,318 images were included. The AUC of AI detection of neoplastic lesions in the stomach, Barrett's esophagus, and squamous esophagus and HP status were .96 (95% confidence interval [CI], .94-.99), .96 (95% CI, .93-.99), .88 (95% CI, .82-.96), and .92 (95% CI, .88-.97), respectively. AI using narrow-band imaging was superior to white-light imaging on detection of neoplastic lesions in squamous esophagus (.92 vs .83, P < .001). The performance of AI was superior to endoscopists in the detection of neoplastic lesions in the stomach (AUC, .98 vs .87; P < .001), Barrett's esophagus (AUC, .96 vs .82; P < .001), and HP status (AUC, .90 vs .82; P < .001). CONCLUSIONS: AI is accurate in the detection of upper GI neoplastic lesions and HP infection status. However, most studies were based on retrospective reviews of selected images, which requires further validation in prospective trials.
BACKGROUND AND AIMS: Artificial intelligence (AI)-assisted detection is increasingly used in upper endoscopy. We performed a meta-analysis to determine the diagnostic accuracy of AI on detection of gastric and esophageal neoplastic lesions and Helicobacter pylori (HP) status. METHODS: We searched Embase, PubMed, Medline, Web of Science, and Cochrane databases for studies on AI detection of gastric or esophageal neoplastic lesions and HP status. After assessing study quality using the Quality Assessment of Diagnostic Accuracy Studies tool, a bivariate meta-analysis following a random-effects model was used to summarize the data and plot hierarchical summary receiver-operating characteristic curves. The diagnostic accuracy was determined by the area under the hierarchical summary receiver-operating characteristic curve (AUC). RESULTS: Twenty-three studies including 969,318 images were included. The AUC of AI detection of neoplastic lesions in the stomach, Barrett's esophagus, and squamous esophagus and HP status were .96 (95% confidence interval [CI], .94-.99), .96 (95% CI, .93-.99), .88 (95% CI, .82-.96), and .92 (95% CI, .88-.97), respectively. AI using narrow-band imaging was superior to white-light imaging on detection of neoplastic lesions in squamous esophagus (.92 vs .83, P < .001). The performance of AI was superior to endoscopists in the detection of neoplastic lesions in the stomach (AUC, .98 vs .87; P < .001), Barrett's esophagus (AUC, .96 vs .82; P < .001), and HP status (AUC, .90 vs .82; P < .001). CONCLUSIONS: AI is accurate in the detection of upper GI neoplastic lesions and HP infection status. However, most studies were based on retrospective reviews of selected images, which requires further validation in prospective trials.
Authors: George E Fowler; Rhiannon C Macefield; Conor Hardacre; Mark P Callaway; Neil J Smart; Natalie S Blencowe Journal: BMJ Open Date: 2021-10-20 Impact factor: 2.692
Authors: Jin Lin Tan; Mohamed Asif Chinnaratha; Richard Woodman; Rory Martin; Hsiang-Ting Chen; Gustavo Carneiro; Rajvinder Singh Journal: Front Med (Lausanne) Date: 2022-06-22